LivaNova profit margin LIVN
Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.
- Net margin, 12 months
- 12.8%
- Operating margin, 12 months
- 12.7%
- Net margin on a year earlier
- +29.0 pts
- Peer median
- 9.4%
Over the twelve months to Jun 30, 2026, LivaNova kept 12.8% of its revenue as net profit, with an operating margin of 12.7% and a gross margin of 68.1%.
Five years earlier its net margin was −37.5%.
The median for 6 medical device stocks of a similar size is 9.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −17.5% | 14.4% | 67.7% |
| FY2024 | 5.0% | 10.3% | 68.8% |
| FY2023 | 1.5% | −5.9% | 66.9% |
| FY2022 | −8.4% | −7.5% | 69.2% |
| FY2021 | −13.1% | −0.1% | 68.2% |
| FY2020 | −37.3% | −29.3% | 63.7% |
| FY2019 | −14.3% | −15.6% | 70.2% |
| FY2018 | −17.1% | −22.4% | 67.4% |
| FY2017 | −2.5% | 9.5% | 64.4% |
| FY2016 | −6.5% | 3.3% | 58.0% |
| FY2015 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 12.8% | +29.0 pts | 12.7% | |
| Q1 FY26 | 7.5% | +24.9 pts | 13.4% | |
| Q4 FY25 | −17.5% | −22.5 pts | 14.4% | |
| Q3 FY25 | −16.1% | −18.0 pts | 14.4% | |
| Q2 FY25 | −16.1% | −14.8 pts | 13.4% | |
| Q1 FY25 | −17.4% | −14.7 pts | 12.7% | |
| Q4 FY24 | 5.0% | +3.5 pts | 10.3% | |
| Q3 FY24 | 1.9% | +1.7 pts | 0.3% | |
| Q2 FY24 | −1.4% | +7.6 pts | −2.2% | |
| Q1 FY24 | −2.7% | +5.2 pts | −4.2% | |
| Q4 FY23 | 1.5% | +10.0 pts | −5.9% | |
| Q3 FY23 | 0.3% | +9.4 pts | 3.0% |
Against its peers
Companies in Medical - Devices nearest LivaNova's size, closest first, today.
| Company | Profit margin |
|---|---|
| LIVNLivaNova | 12.8% |
| ITGRInteger | 7.0% |
| TMDXTransMedics | 22.7% |
| CNMDCONMED | 4.1% |
| ZBHZimmer Biomet | 9.5% |
| DXCMDexCom | 20.1% |
| GEHCGE HealthCare Technologies | 9.3% |
| Peer median | 9.4% |
Where LivaNova ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on LivaNova
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.